Novo Nordisk to create 6000 jobs by 2022


Danish insulin and diabetes specialist Novo Nordisk says it intends to employ 6000 more highly skilled workers within Denmark by 2022. Half of these new staff will work in R&D. The announcement bucks the trend of recent years in pharma, which has tended to see companies downsizing drastically and closing R&D sites.

The company used its announcement to call on the Danish government to prioritise investment in research-based training in the sciences to ensure that research-driven Danish companies can continue to grow. ‘It will be crucial for Novo Nordisk that Denmark educates world-class graduates but also focuses far more intently on attracting international talent,’ said the firm’s chief science officer, Mads Krogsgaard Thomsen in a statement.


Related Content

$100m of diabetes R&D in China

24 September 2012 Business

news image

Novo Nordisk will create 130–200 new research jobs

Business roundup

29 November 2010 Business

news image

Industry news, December 2010

Most Read

Photon pinball identifies chemicals from afar

13 August 2014 Research

news image

Samples turned into random Raman lasers beam their secrets from over a kilometre away

History of King Richard III written in his teeth

18 August 2014 Research

news image

Chemical analysis of isotope signatures in monarch's remains provide insight into his life

Most Commented

Catching criminals' coffee adulteration

12 August 2014 Research

news image

A test can detect unwelcome extra ingredients in coffee by analysing the drink's sugar fingerprint

Radiolabels help evaluate emerging cancer treatment

18 August 2014 Research

news image

Tracking tools will aid transition of boron neutron capture therapy from bench to hospital